Alexander Knuth, M.D.

Hamad Medical Corporation
Doha, Qatar

Dr. Alexander Knuth is the medical director and chief executive officer of the National Center for Cancer Care and Research at Hamad Medical Corporation.

Dr. Knuth’s pioneering work in cancer immunology led to the discovery of multiple human cancer antigens including MAGE, the first of the so-called cancer/testis (CT) antigens that have been a primary target of vaccine strategies to date. He also played a pivotal role in the development of peptide-based vaccines and adjuvants, established immune-monitoring techniques, and discovered tumor escape mechanisms. He has received many awards, including the prestigious Johann-Georg-Zimmermann Medal.

In addition to being a member of CRI’s Scientific Advisory Council, Dr. Knuth serves on the CLIP Grant Review Committee and is a member of CRI’s global clinical investigator network.

All women are at risk for breast cancer. But, when breast cancer is caught early and treated, survival rates can be increased.
Let's spread the word about Immunotherapy! Click to share this page with your community.

*Immunotherapy results may vary from patient to patient.